MM+M Podcast 10.20.22: FDA panel vote doesn’t go well for Makena, and MM+M holds its 19th awards show
Episode Description
Lecia explains this week’s FDA advisory committee hearing on whether to withdraw Covis Pharma’s preterm birth drug Makena from the market, and what the case means for the agency’s larger accelerated approval pathway. She also speaks with a few of the winners at this month’s MM+M Awards ceremony.
Follow us on twitter: @MMMnews
Check us out at: mmm-online.com
Follow us:
YouTube: @MMM-online
TikTok: @MMMnews
Instagram: @MMMnewsonline
Twitter/X: @MMMnews
LinkedIn: MM+M
To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.
Music: “Deep Reflection” by DP and Triple Scoop Music.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Listen On
